Why the Advanced Human Imaging (ASX:AHI) share price is jumping 15%

The Advanced Human Imaging (ASX:AHI) share price is jumping 15% higher on Thursday following an announcement…
The post Why the Advanced Human Imaging (ASX:AHI) share price is jumping 15% appeared first on The Motley Fool Australia. –

The Advanced Human Imaging Ltd (ASX: AHI) share price has been a very strong performer on Thursday.

 In afternoon trade, the software company’s shares are up over 15% to $1.82.

Why is the Advanced Human Imaging share price surging higher?

Investors have been buying the shares of Advanced Human Imaging, formerly known as MyFiziq, following the release of an announcement today.

According to the release, the company has signed a binding terms sheet with US based on-device blood pathology company Jana Care.

The release explains that Jana Care has developed and patented an on-device blood screening tool called Aina. The patented Aina device is capable of providing rapid, accurate readouts of key blood chemistry elements in several chronic disease categories – cardiovascular, renal and metabolic (CVRM). It is used in over 1,500 clinics by over 10,000 health workers with more than 200,000 patients.

The company notes that the device delivers rapid, accurate readouts that are extremely valuable for healthcare partners and patients that have deployed personal health management apps via their carers, life/health insurers, wellness managers, fitness organizations, and telehealth doctors/facilities.

Furthermore, the device avoids the need for the patient to go to a medical facility or phlebologist to provide blood and then wait for the results.

What now?

The Aina device diagnostic solution will be provided by Advanced Human Imaging via its CompleteScan app to its partners for their onward use by selected persons whose blood chemistry information is needed on a timely and accurate basis.

The first demonstratable product is expected to be made available in the third quarter of 2021.

Advanced Human Imaging’s Chief Executive Officer, Vlado Bosanac, commente: “The commercial distribution arrangement we have undertaken with Jana is an extremely important addition to the remote care and health assessment platform we are delivering to our partners and the vast communities they service around the world. The work Jana has and is doing in the care and identification of chronic disease is of paramount importance and a perfect addition to our offering.”

“The use case is powerful, when a user performs a FaceScan or a BodyScan we are able to detect a number of potential risk parameters that relate to chronic diseases. These markers are not dissimilar to the checks a doctor would perform when a patient is attending the doctors practice. If the performed scans identify any of the markers, this will assist the care provider in the need to facilitate a blood test, at which time via the Aina device we will facilitate the draw, analysis and diagnostic reports for both the patient, doctor and care provider.”

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

*Returns as of February 15th 2021

More reading

Advanced Human Imaging (ASX:AHI) share price is sinking, but why?
Advanced Human Imaging (ASX:AHI) share price sinks despite positive update
Advanced Human Imaging (ASX:AHI) share price wobbles on agreement
What’s with the Advanced Human Imaging (ASX:AHI) share price today?

The post Why the Advanced Human Imaging (ASX:AHI) share price is jumping 15% appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!